The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.
Victory Trivalent Intl Fd-Core Eq Y MICYX
- NAV / 1-Day Return 8.25 / +1.23 %
- Total Assets 219.2 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.700%
- Distribution Fee Level Below Average
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 1.0 Mil
- Status Open
- TTM Yield 3.45%
- Turnover 49%
USD | NAV as of Jul 27, 2024 | 1-Day Return as of Jul 27, 2024, 12:08 AM GMT+0
Morningstar’s Analysis MICYX
Will MICYX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 14.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 2.67 | 5.9 Mil | Healthcare |
Taiwan Semiconductor Manufacturing Co Ltd | 2.56 | 5.6 Mil | Technology |
Novartis AG Registered Shares | 1.66 | 3.6 Mil | Healthcare |
Samsung Electronics Co Ltd | 1.18 | 2.6 Mil | Technology |
Siemens AG | 1.09 | 2.4 Mil | Industrials |
ASML Holding NV | 1.08 | 2.4 Mil | Technology |
Sumitomo Mitsui Financial Group Inc | 1.05 | 2.3 Mil | Financial Services |
ITOCHU Corp | 1.00 | 2.2 Mil | Industrials |
3i Group Ord | 0.99 | 2.2 Mil | Financial Services |
Fairfax Financial Holdings Ltd | 0.97 | 2.1 Mil | Financial Services |